We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West Pharmaceutical Services, Inc. (NYSE: WST) is pleased to announce that West's contract manufacturing, has received a 2015 Manufacturing Leadership Award in the Engineering and Production Technology Leadership category from Frost & Sullivan’s Manufacturing Leadership Council.
The award recognizes Wes't contract manufacturing team's innovative process monitoring strategy, an initiative known as E2: Every Machine, Every Part. This enterprise-wide initiative reviews and improves control processes by integrating a state-of-the-art process monitoring system across 300 molding machines at all seven of West's contract manufacturing facilities throughout North America.
“We’re extremely honored to receive Frost & Sullivan’s award recognizing our significant investment and commitment to quality and process manufacturing excellence,” said Mike Treadaway, West's contract manufacturing President, PDS Contract Manufacturing, West Pharmaceutical Services. “As a key supplier of life-saving medical devices and critical components, we are constantly looking for ways to improve product quality. The Manufacturing Leadership Award is validation of the hard work and effort by the entire organization. The E2 initiative ensures our customers and their end users benefit from unmatched technical expertise and quality-driven manufacturing processes.”
The E2 initiative was launched as a pilot program in 2011 at West's contract manufacturing Michigan plant. Its Process Excellence department tested manufacturing process discrepancies, including identifying sources of product variation and detecting product defects in real time. West contact manufacturing team heavily engaged in Six Sigma training since 2001, was able to leverage its experience in statistics and data collection, which was a critical step in the process. These findings led to new training programs, quality-focused infrastructure improvements and project management initiatives across West’s contract manufacturing facilities. Under the standardized process monitoring approach, it enhanced business processes by reducing manufacturing scrap, correcting up-time for post-injection molding assembly activities, and improving outgoing quality and on-time delivery to satisfy customers’ needs.
The Manufacturing Leadership Awards, now in their 11th year, honor manufacturing companies and individual leaders that are shaping the future of global manufacturing. Winning individuals and projects have demonstrated achievement in one of a wide range of categories. They are chosen by a panel of expert judges for results that enabled the manufacturers to set themselves apart from their competitors and that have delivered clear and compelling value, return on investment, and other tangible outcomes.
Frost & Sullivan will present the Manufacturing Leadership Award to West's contract manufacturing team at the 11th Annual Manufacturing Leadership Awards Gala on June 4, 2015, at the Omni La Costa Resort & Spa in Carlsbad, California.
<p>Color has a surprising number of uses in injectables packaging.</p><p>European guidance states that “similarity in packaging which contributes to medication error can be reduced by the judicious use of color on the pack” ¹. Draft guidance issued by the U.S Food and Drug Administration (FDA)² similarly recommends that “sponsors use color prudently to bring attention to the product name, strength, and important warning(s).” Color – when applied thoughtfully and with full awareness of the context in which the drug will be used – can be an important way for manufacturers to help practitioners and patients differentiate products and support their correct use.</p>
Diane Paskiet, Director, Scientific Affairs, serves as co-chair for the 2014 PDA Packaging Conference: Pharmaceutical Packaging Systems – <em>Current and Emerging Practices, Technologies and Materials</em>, which will be held at the Washington Marriott Wardman Park, Washington, D.C. on May 20-21, 2014.
The global injectable drug market sees an ever-increasing adoption of high-value biologic drug products. More than half of today’s 20 top selling injectables are biologics, and many of them are delivered in a prefilled syringe. Even though glass syringes are predominantly used for primary containment of parenterals, the (bio)pharmaceutical industry continues to cope with certain limitations associated with glass prefilled systems.
Diane Paskiet, Director Scientific Affairs, will provide an update on the PQRI-PODP working group at the Smithers Rapra Extractables and Leachables conference in Barcelona, Spain on November 10-12, 2014.
Our team in Waterford, Ireland recently welcomed its newest “team member.” In partnership with BUMBLEance, the team is excited to launch the new children’s regional ambulance service, BUMBLEance #15, which will operate and service children from the Southeast Region of Ireland. The new vehicle will be permanently based in Waterford’s car park.
English
Chinese
